甲氰菊酯最大残留限量（MRLs）的针对性审查。
Targeted review of maximum residue levels (MRLs) for fenpropathrin.
作者信息
Bellisai Giulia, Bernasconi Giovanni, Binaglia Marco, Brancato Alba, Carrasco Cabrera Luis, Castellan Irene, Castoldi Anna Federica, Chiusolo Arianna, Crivellente Federica, Del Aguila Monica, Ferreira Lucien, Santonja German Giner, Greco Luna, Istace Frederique, Jarrah Samira, Lanzoni Anna, Leuschner Renata, Mangas Iris, Miron Ileana, Nave Stefanie, Panzarea Martina, Parra Morte Juan Manuel, Pedersen Ragnor, Reich Hermine, Ruocco Silvia, Santos Miguel, Scarlato Alessia Pia, Terron Andrea, Theobald Anne, Tiramani Manuela, Verani Alessia
出版信息
EFSA J. 2023 Jun 19;21(6):e08057. doi: 10.2903/j.efsa.2023.8057. eCollection 2023 Jun.
In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to review the existing maximum residue levels (MRLs) for the non-approved active substance fenpropathrin in view of the possible lowering of the MRLs. EFSA investigated the origin of the current EU MRLs. For existing EU MRLs that reflect previously authorised uses in the EU, or that are based on obsolete Codex Maximum Residue Limits, or import tolerances that are not required any longer, EFSA proposed the lowering to the limit of quantification or to an alternative MRL. EFSA performed an indicative chronic and acute dietary risk assessment for the revised list of MRLs to allow risk managers to take the appropriate decisions.
根据欧盟法规（EC）396/2005第43条，欧洲食品安全局（EFSA）收到欧盟委员会的请求，要求鉴于可能降低最大残留限量（MRLs），对未批准的活性物质甲氰菊酯的现有最大残留限量进行审查。EFSA调查了当前欧盟最大残留限量的来源。对于反映欧盟先前授权用途的现有欧盟最大残留限量，或基于过时的食品法典委员会最大残留限量，或不再需要的进口容忍度，EFSA提议将其降低到定量限或替代最大残留限量。EFSA对修订后的最大残留限量清单进行了指示性慢性和急性膳食风险评估，以便风险管理者做出适当决策。
Zotero 插件